Clinical Effect Analysis of Fire‐needle Acupuncture at Neiyingxiang Treating Persistent Allergic Rhinitis

Objectives We conducted the first trial to evaluate the effect that fire‐needle acupuncture at Neiyingxiang (ExHN 9) in patients with moderate to severe persistent AR. Methods This was a randomized, single‐center, sham, and placebo‐controlled rial. Patients were kept blinded to their group assignment. All participants were equally assigned to the fire‐needle acupuncture (FA) treatment group, sham fire‐needle acupuncture (SFA) group, or loratadine group. The trial was designed with an acupuncture intervention once a week for 4 weeks and follow‐up 4 weeks. The Total Nasal Symptom Scores (TNSS), Total Non‐Nasal Symptom Scores (TNNSS), Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), Allergic Rhinitis Control Test (ARCT), and total nasal resistance of 150 Pa were evaluated as outcome measures. Results A total of 180 participants were enrolled, and 175 participants completed the trials. At 2 and 4 weeks, the TNSS, TNNSS, and RQLQ scores of the FA and loratadine groups were significantly lower than those of the SFA group. At 8 weeks, the scores of loratadine group increased compared with the FA group (Cohen's d >0.80, p < 0.01). The ACRT score of the FA treatment group rose gradually. After treatment, the total nasal resistance of the FA group was significantly decreased and was lower than that of the other two groups (Cohen's d >0.80, p < 0.01). Conclusion Fire‐needle acupuncture at Neiyingxiang (ExHN 9) is effective for improving nasal allergy symptoms and quality of life in patients with moderate and severe persistent AR, and the duration of its effects is long. Level of Evidence 2 Laryngoscope , 2024